| Authors: |
Roberts TJ; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Meador CB; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Fuld AD; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA., Lasko A; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Frigault M; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Hangar KM; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Reynolds K; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA., Sadow PM; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Wirth LJ; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Mass General Brigham Cancer Institute, Boston, Massachusetts, USA. |
